Patents by Inventor Joerg HUELSKEN

Joerg HUELSKEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8969080
    Abstract: Disclosed is the use of inhibitors of ?-catenin expression or activity or modulators downregulating ?-catenin expression or activity for the treatment of cardiovascular diseases or disorders and their use in the treatment of cardiovascular diseases and disorders, such as heart failure syndrome. The use of those agents resulted in particular in cardiomyocyte differentiation of endogenous cardiac stem cells.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: March 3, 2015
    Assignee: Max-Delbrueck-Centrum fuer Molekulare Medizin
    Inventors: Martin Bergmann, Joerg Huelsken, Walter Birchmeier, Makoto Mark Taketo
  • Publication number: 20100255041
    Abstract: Disclosed is the use of inhibitors of ?-catenin expression or activity or modulators downregulating ?-catenin expression or activity for the treatment of cardiovascular diseases or disorders and their use in the treatment of cardiovascular diseases and disorders, such as heart failure syndrome. The use of those agents resulted in particular in cardiomyocyte differentiation of endogenous cardiac stem cells.
    Type: Application
    Filed: October 5, 2009
    Publication date: October 7, 2010
    Applicant: MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN
    Inventors: Martin BERGMANN, Joerg HUELSKEN, Walter BIRCHMEIER, Makoto Mark TAKETO